In order to demonstrate whether NSCLC-derived TEVs were able to mediate cancer progression by modulating the immune response, the levels of the immune checkpoint PD-L1 in TEVs isolated from unstimulated and IL-1β-stimulated cells as well as in OR cells were assessed (Figure 5). The gene discussed is CD274; the disease is non-small cell lung carcinoma.